Multiple Sclerosis, Relapsing-Remitting research hub

Biomarkers of aHSCT

This study looks at how a stem cell transplant (aHSCT) works for multiple sclerosis (MS) and other immune-related brain conditions. Researchers want to understand why it helps some people more than others and find ways to predict its success or failure.

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

This study is testing a new tablet, IMU-838, for people aged 18-55 with a type of multiple sclerosis (MS) called relapsing MS. It wants to see how well it works, if it's safe, and if people can tolerate it compared to a dummy tablet.

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS